Zhang H, Ge C, Fisher D, Hien N, Musabaev E, Pronyuk K
Virol J. 2025; 22(1):62.
PMID: 40050867
PMC: 11887211.
DOI: 10.1186/s12985-025-02666-1.
Pathak T, Gupta K, Kumar N, Banerjee I
Methods Mol Biol. 2025; 2890:103-123.
PMID: 39890723
DOI: 10.1007/978-1-0716-4326-6_5.
Muniz-Trejo R, Park Y, Thornton J
bioRxiv. 2025; .
PMID: 39763774
PMC: 11702759.
DOI: 10.1101/2024.12.20.629812.
Lee S, Lee D, Min D, Park S, Kim D, Kim E
Prev Nutr Food Sci. 2024; 29(3):332-344.
PMID: 39371516
PMC: 11450288.
DOI: 10.3746/pnf.2024.29.3.332.
Mai L, Wimberley S, Champion J
Nanoscale. 2024; 16(33):15465-15480.
PMID: 39091235
PMC: 11340348.
DOI: 10.1039/d4nr02093f.
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity.
Moirangthem R, Cordela S, Khateeb D, Shor B, Kosik I, Schneidman-Duhovny D
Mol Ther. 2024; 32(10):3712-3728.
PMID: 39086132
PMC: 11489563.
DOI: 10.1016/j.ymthe.2024.07.023.
High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces.
Sonnentag S, Jenne F, Orian-Rousseau V, Nesterov-Mueller A
Commun Biol. 2024; 7(1):870.
PMID: 39020032
PMC: 11255233.
DOI: 10.1038/s42003-024-06541-7.
Diversity of genotypes and pathogenicity of H9N2 avian influenza virus derived from wild bird and domestic poultry.
Yang Q, Ji J, Yang J, Zhang Y, Yin H, Dai H
Front Microbiol. 2024; 15:1402235.
PMID: 38974026
PMC: 11225357.
DOI: 10.3389/fmicb.2024.1402235.
One-pot synthesis, characterization and antiviral properties of new benzenesulfonamide-based spirothiazolidinones.
Apaydin C, Naesens L, Cihan-Ustundag G
Mol Divers. 2024; 28(4):2681-2688.
PMID: 38935302
PMC: 11450120.
DOI: 10.1007/s11030-024-10912-x.
Molecular Markers and Mechanisms of Influenza A Virus Cross-Species Transmission and New Host Adaptation.
Guo X, Zhou Y, Yan H, An Q, Liang C, Liu L
Viruses. 2024; 16(6).
PMID: 38932174
PMC: 11209369.
DOI: 10.3390/v16060883.
R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K.
Tang J, Zou S, Zhou J, Gao R, Xin L, Zeng X
Emerg Microbes Infect. 2024; 13(1):2373314.
PMID: 38922326
PMC: 467099.
DOI: 10.1080/22221751.2024.2373314.
H19 influenza A virus exhibits species-specific MHC class II receptor usage.
Karakus U, Mena I, Kottur J, El Zahed S, Seoane R, Yildiz S
Cell Host Microbe. 2024; 32(7):1089-1102.e10.
PMID: 38889725
PMC: 11295516.
DOI: 10.1016/j.chom.2024.05.018.
Emergence of Eurasian Avian-Like Swine Influenza A (H1N1) virus in a child in Shandong Province, China.
He Y, Song S, Wu J, Wu J, Zhang L, Sun L
BMC Infect Dis. 2024; 24(1):550.
PMID: 38824508
PMC: 11143696.
DOI: 10.1186/s12879-024-09441-7.
Probing altered receptor specificities of antigenically drifting human H3N2 viruses by chemoenzymatic synthesis, NMR, and modeling.
Unione L, Ammerlaan A, Bosman G, Uslu E, Liang R, Broszeit F
Nat Commun. 2024; 15(1):2979.
PMID: 38582892
PMC: 10998905.
DOI: 10.1038/s41467-024-47344-y.
Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic.
Zeng J, Du F, Xiao L, Sun H, Lu L, Lei W
J Virol. 2024; 98(3):e0140123.
PMID: 38358287
PMC: 10949427.
DOI: 10.1128/jvi.01401-23.
C1QTNF5 is a novel attachment factor that facilitates the entry of influenza A virus.
Yu L, Liu X, Wei X, Ren J, Wang X, Wu S
Virol Sin. 2024; 39(2):277-289.
PMID: 38246238
PMC: 11074642.
DOI: 10.1016/j.virs.2024.01.003.
H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic.
Liu M, Bakker A, Narimatsu Y, van Kuppeveld F, Clausen H, de Haan C
Proc Natl Acad Sci U S A. 2023; 120(31):e2304992120.
PMID: 37467282
PMC: 10401031.
DOI: 10.1073/pnas.2304992120.
Quinones as Promising Compounds against Respiratory Viruses: A Review.
Chan-Zapata I, Borges-Argaez R, Ayora-Talavera G
Molecules. 2023; 28(4).
PMID: 36838969
PMC: 9967002.
DOI: 10.3390/molecules28041981.
Influenza and Universal Vaccine Research in China.
Li J, Zhang Y, Zhang X, Liu L
Viruses. 2023; 15(1).
PMID: 36680158
PMC: 9861666.
DOI: 10.3390/v15010116.
Global Infection Rate of Rotavirus C during 1980-2022 and Analysis of Critical Factors in the Host Range Restriction of Virus VP4.
Zhao S, Jin X, Zang L, Liu Z, Wen X, Ran X
Viruses. 2022; 14(12).
PMID: 36560830
PMC: 9781963.
DOI: 10.3390/v14122826.